An Innovative Virtually Supervised Exercise for Dialysis Patients

Sponsor
Baylor College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT03076528
Collaborator
Hamad Medical Corporation (Industry), Qatar National Research Foundation (QNRF), Award # NPRP 7-1595-3-405 (Other)
100
1
2
27
3.7

Study Details

Study Description

Brief Summary

Among patients with diabetes 35% suffer from chronic renal disease and may require dialysis or kidney replacement over time. Furthermore, in diabetics with end stage renal disease (ESRD) that require dialysis, the risk of foot complications and amputation is even more common, expensive, and devastating. Interestingly, even though incidence of foot ulcers in patients with dialysis has been reported to be same as with patients with history of foot ulcers; dialysis patients have significantly higher rate of foot amputation.

The goal of this research is to incorporate an innovative virtually supervised non-weight bearing exercise in patients undergoing dialysis to reduce risk of fall and foot ulceration by enhancing lower extremity blood flow, joint perception and joint mobility.

Diabetic patients on hemodialysis at Hamad Medical Company will be recruited and will be randomized to either intervention (IG) or control (CG) group and followed for 6 months. The intervention group will take part in a 4-week non-weight bearing exercise program twice per week at the hemodialysis clinic under the supervision of a qualified research staff member. This intervention includes interactive game-based exercises including repetitive ankle and foot movements. Wearable sensors will provide real-time visual/auditory feedback from foot and ankle position and allowed perception of motor-errors during each motor-action. The control group will be instructed to complete a supervised foot and ankle exercise without using sensor technology. Changes in balance, gait, and physical activity, incidence of foot problems will be compared pre- and post-intervention. In addition, the incident of falls, foot ulcers, and limb amputation up to 6 months post intervention will be documented. Investigators hypothesize that patients receiving sensor-based exercises will benefit more compared to group receiving conventional non-technology training in terms of improving functional performance and reducing incidence of foot problems, falls, and limb amputation.

Condition or Disease Intervention/Treatment Phase
  • Other: Sensor-based interactive exercise (game-based exercise)
  • Other: Non-technology foot and ankle exercise program
Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
An Innovative Virtually Supervised Exercise for Dialysis Patients
Actual Study Start Date :
Nov 6, 2016
Actual Primary Completion Date :
Jan 6, 2019
Actual Study Completion Date :
Feb 6, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention with game-based exercise

Subjects will be receiving sensor-based interactive ankle & foot exercise program (game-based exercise) during hemo-dialysis, approximately 30 minutes, twice per week and for 4 weeks.

Other: Sensor-based interactive exercise (game-based exercise)
This intervention includes interactive game-based lower extremity training including repetitive ankle movements in multiple directions. Wearable sensors will provide real-time feedback from foot and ankle position and allow perception of motor-errors during each motor-action

Active Comparator: Non-technology foot and ankle exercise program

Subjects will be receiving non-technology foot and ankle exercise program during hemodialysis, approximately 30 minutes, twice per week and for 4 weeks.

Other: Non-technology foot and ankle exercise program
Subjects are asked to perform non-technology based foot and ankle exercises, which include plantar flexion and extension.

Outcome Measures

Primary Outcome Measures

  1. Gait Speed change from Baseline to 4 weeks [Baseline and 4 weeks]

    walking ability is quantified by gait speed

  2. Balance change from Baseline to 4 weeks quantified by body sway [Baseline and 4 weeks]

    Balance is quantified by body sway

Secondary Outcome Measures

  1. Fear of Falling change from Baseline to 4 weeks using Fall Efficacy Scale International (FES-I) questionnaire [Baseline and 4 weeks]

    Measuring fear of falling using Fall Efficacy Scale International (FES-I) questionnaire

  2. Depression change from Baseline to 4 weeks using Center of Epidemiologic Depression Scale (CES-D) questionnaire [Baseline to 4 weeks]

    Measuring depression using Center of Epidemiologic Depression Scale (CES-D) questionnaire

  3. Change of Incident of falls [Baseline and 6 months]

  4. Change of Incidents of foot problems [Baseline and 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults of 50 years or older, who are undergoing hemodialysis process

  • Patients in diabetes

  • Ability to provide consent

Exclusion Criteria:
  • Non-ambulatory patients (unable to walk independently a distance of 20m with or without existence)

  • Active foot ulcer

  • Major foot amputation

  • Charcot neuroarthropathy

  • Major hearing/vision impaired

  • Any patient with changes in psychotropic or sleep medications in the last 6 weeks

  • Patients concurrently participating in another exercise training

  • Patients with any clinically significant medical or psychiatric condition, or laboratory abnormality

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hamad Medical Coorporation Doha Qatar

Sponsors and Collaborators

  • Baylor College of Medicine
  • Hamad Medical Corporation
  • Qatar National Research Foundation (QNRF), Award # NPRP 7-1595-3-405

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bijan Najafi, PhD, Professor of Surgery, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT03076528
Other Study ID Numbers:
  • H-38522
First Posted:
Mar 10, 2017
Last Update Posted:
May 6, 2019
Last Verified:
May 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bijan Najafi, PhD, Professor of Surgery, Baylor College of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2019